Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray

NCT01405339 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis

Interventions

DEVICE: Mucosal Atomization Device (MAD)
DEVICE: Budesonide via Nasal Syringe

Sponsor

St. Paul's Hospital, Canada